Olopatadine

Results: 28



#Item
11Division: Pharmacy Services  Subject: Prior Authorization Criteria Original Development Date: Original Effective Date:

Division: Pharmacy Services Subject: Prior Authorization Criteria Original Development Date: Original Effective Date:

Add to Reading List

Source URL: www.fdhc.state.fl.us

Language: English - Date: 2012-09-25 12:12:06
12PHARMACIST Give to Patient  Patient Instructions for Use Nasal Spray (olopatadine hydrochloride)

PHARMACIST Give to Patient Patient Instructions for Use Nasal Spray (olopatadine hydrochloride)

Add to Reading List

Source URL: ecatalog.alcon.com

Language: English - Date: 2014-08-21 13:04:53
13These highlights do not include all the information needed to use PATANASE® Nasal Spray safely and effectively. See full prescribing information for PATANASE Nasal Spray. PATANASE (olopatadine hydrochloride) Nasal Spray

These highlights do not include all the information needed to use PATANASE® Nasal Spray safely and effectively. See full prescribing information for PATANASE Nasal Spray. PATANASE (olopatadine hydrochloride) Nasal Spray

Add to Reading List

Source URL: ecatalog.alcon.com

Language: English - Date: 2014-08-21 13:04:53
14HIGHLIGHTS OF PRESCRIBING INFORMATION  DOSAGE AND ADMINISTRATION ADVERSE REACTIONS

HIGHLIGHTS OF PRESCRIBING INFORMATION DOSAGE AND ADMINISTRATION ADVERSE REACTIONS

Add to Reading List

Source URL: ecatalog.alcon.com

Language: English - Date: 2014-08-21 13:04:53
15Abbreviated Process for PAC- No Presentation Full Safety Review Provided in Briefing Packet * Patanase Spray (olopatadine HCl) * Astepro Spray (azelastine HCl) * Bepreve (bepotastine besilate ophthalmic solution) 1.5% *

Abbreviated Process for PAC- No Presentation Full Safety Review Provided in Briefing Packet * Patanase Spray (olopatadine HCl) * Astepro Spray (azelastine HCl) * Bepreve (bepotastine besilate ophthalmic solution) 1.5% *

Add to Reading List

Source URL: www.fda.gov

    16CLINICAL REVIEW   Application Type Submission Number Submission Code

    CLINICAL REVIEW Application Type Submission Number Submission Code

    Add to Reading List

    Source URL: www.fda.gov

    Language: English
    17022288_Bepotastine_Clinical_PREA

    022288_Bepotastine_Clinical_PREA

    Add to Reading List

    Source URL: www.fda.gov

    Language: English
    18Statistical Review and Evaluation Clinical Studies

    Statistical Review and Evaluation Clinical Studies

    Add to Reading List

    Source URL: www.fda.gov

    Language: English
    19Clinical Pharmacology Review

    Clinical Pharmacology Review

    Add to Reading List

    Source URL: www.fda.gov

    Language: English
    20Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology

    Department of Health and Human Services Public Health Service Food and Drug Administration Center for Drug Evaluation and Research Office of Surveillance and Epidemiology

    Add to Reading List

    Source URL: www.fda.gov

    Language: English